Safest Stocks for Volatile Markets
Defensive, low-beta stocks with high quality scores and stable dividends.
| # | Ticker | Company | Price | 1D | Quality | Valuation | Market Cap |
|---|---|---|---|---|---|---|---|
| 1 | TGTX | TG Therapeutics, Inc. | $33.53 | -0.1% | 100 | Undervalued | $5.4B |
| 2 | VRTX | Vertex Pharmaceuticals Incorporated | $438.71 | -1.9% | 100 | Undervalued | $111.4B |
| 3 | ISRG | Intuitive Surgical, Inc. | $452.07 | -2.7% | 100 | Undervalued | $160.6B |
| 4 | INCY | Incyte Corporation | $95.93 | +1.7% | 100 | Undervalued | $19.1B |
| 5 | VEEV | Veeva Systems Inc. | $173.98 | +0.7% | 100 | Undervalued | $28.6B |
| 6 | MNST | Monster Beverage Corporation | $72.37 | -0.6% | 100 | Overvalued | $70.8B |
| 7 | ZTS | Zoetis Inc. | $117.94 | +0.6% | 100 | Undervalued | $52.0B |
| 8 | HALO | Halozyme Therapeutics, Inc. | $64.49 | -1.4% | 100 | Deeply Undervalued | $7.6B |
| 9 | RMD | ResMed Inc. | $224.09 | +0.6% | 100 | Undervalued | $32.7B |
| 10 | KRYS | Krystal Biotech, Inc. | $260.95 | +0.8% | 100 | Undervalued | $7.6B |
| 11 | NBIX | Neurocrine Biosciences, Inc. | $131.60 | -0.7% | 100 | Undervalued | $13.2B |
| 12 | ORNBV.HE | Orion Oyj | $71.70 | -0.1% | 100 | — | $10.1B |
| 13 | UTHR | United Therapeutics Corporation | $564.81 | -1.0% | 100 | Undervalued | $24.8B |
| 14 | EXEL | Exelixis, Inc. | $43.88 | -0.4% | 100 | Undervalued | $11.8B |
| 15 | ILMN | Illumina, Inc. | $127.38 | +0.6% | 95 | Undervalued | $19.5B |
| 16 | ALKS | Alkermes plc | $34.84 | -0.6% | 95 | Undervalued | $5.8B |
| 17 | ARWR | Arrowhead Pharmaceuticals, Inc. | $61.03 | -3.0% | 95 | Undervalued | $8.5B |
| 18 | GMAB.CO | Genmab A/S | $1,758.50 | +2.7% | 95 | — | $108.0B |
| 19 | GILD | Gilead Sciences, Inc. | $139.71 | -0.4% | 95 | Undervalued | $173.4B |
| 20 | AWK | American Water Works Company, Inc. | $138.14 | +1.0% | 95 | Undervalued | $27.0B |
| 21 | REGN | Regeneron Pharmaceuticals, Inc. | $761.85 | -2.0% | 95 | Undervalued | $80.5B |
| 22 | LLY | Eli Lilly and Company | $935.58 | -2.0% | 95 | Deeply Overvalued | $837.4B |
| 23 | BIO | Bio-Rad Laboratories, Inc. | $279.99 | +0.6% | 95 | Undervalued | $7.6B |
| 24 | EW | Edwards Lifesciences Corporation | $81.05 | -0.3% | 95 | Undervalued | $47.1B |
| 25 | GMED | Globus Medical, Inc. | $87.92 | +0.2% | 95 | Undervalued | $11.9B |
| 26 | MRK | Merck & Co., Inc. | $120.87 | +0.0% | 95 | Undervalued | $298.8B |
| 27 | NEE | NextEra Energy, Inc. | $93.15 | +0.3% | 95 | Undervalued | $194.1B |
| 28 | PEN | Penumbra, Inc. | $330.36 | +0.4% | 95 | Overvalued | $13.0B |
| 29 | EIX | Edison International | $73.46 | -0.2% | 90 | Undervalued | $28.3B |
| 30 | KO | The Coca-Cola Company | $76.72 | +0.8% | 90 | Fair Value | $330.2B |
| 31 | JNJ | Johnson & Johnson | $243.04 | -0.4% | 90 | Undervalued | $585.7B |
| 32 | RPRX | Royalty Pharma plc | $48.57 | +0.2% | 90 | Undervalued | $28.1B |
| 33 | SCATC.OL | Scatec ASA | $133.20 | +2.0% | 90 | — | $21.3B |
| 34 | NOVN.SW | Novartis AG | $123.20 | +0.2% | 90 | — | $235.1B |
| 35 | IDXX | IDEXX Laboratories, Inc. | $569.55 | +0.9% | 90 | Undervalued | $45.3B |
| 36 | MEDP | Medpace Holdings, Inc. | $498.34 | +1.8% | 90 | Undervalued | $14.1B |
| 37 | SWX | Southwest Gas Holdings, Inc. | $89.24 | +2.0% | 90 | Undervalued | $6.5B |
| 38 | BIIB | Biogen Inc. | $177.34 | -3.5% | 90 | Undervalued | $26.0B |
| 39 | RKT.L | Reckitt Benckiser Group plc | $5,188.00 | +0.1% | 90 | — | $33.4B |
| 40 | DXCM | DexCom, Inc. | $62.22 | -0.2% | 90 | Undervalued | $24.3B |
| 41 | HOLX | Hologic, Inc. | $75.65 | +0.1% | 90 | Undervalued | $16.9B |
| 42 | PTCT | PTC Therapeutics, Inc. | $67.77 | -1.4% | 90 | Undervalued | $5.6B |
| 43 | AMGN | Amgen Inc. | $347.94 | -1.5% | 90 | Undervalued | $187.6B |
| 44 | ATO | Atmos Energy Corporation | $188.97 | +1.9% | 90 | Undervalued | $31.3B |
| 45 | NOVO-B.CO | Novo Nordisk A/S | $236.90 | +2.6% | 90 | — | $1.1T |
| 46 | NVO | Novo Nordisk A/S | $36.98 | +1.4% | 90 | Deeply Undervalued | $164.1B |
| 47 | HQY | HealthEquity, Inc. | $84.67 | +1.6% | 90 | Undervalued | $7.2B |
| 48 | BMRN | BioMarin Pharmaceutical Inc. | $55.50 | -3.0% | 90 | Undervalued | $10.7B |
| 49 | NG.L | National Grid plc | $1,323.00 | +2.2% | 90 | — | $65.8B |
| 50 | ROG.SW | Roche Holding AG | $318.00 | -0.1% | 90 | — | $256.4B |
AI-generated screening for informational purposes only. Not investment advice. Data updated daily.